These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 7625423)

  • 1. The decision to enter a randomized trial of tamoxifen for the prevention of breast cancer in healthy women: an analysis of the tradeoffs.
    Nease RF; Ross JM
    Am J Med; 1995 Aug; 99(2):180-9. PubMed ID: 7625423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival impact of tamoxifen use for breast cancer risk reduction: projections from a patient-specific Markov model.
    Col NF; Goldberg RJ; Orr RK; Erban JK; Fortin JM; Chlebowski RT
    Med Decis Making; 2002; 22(5):386-93. PubMed ID: 12365480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First do no harm: extending the debate on the provision of preventive tamoxifen.
    Will BP; Nobrega KM; Berthelot JM; Flanagan W; Wolfson MC; Logan DM; Evans WK
    Br J Cancer; 2001 Nov; 85(9):1280-8. PubMed ID: 11720461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First results from the International Breast Cancer Intervention Study (IBIS-I): a randomised prevention trial.
    Cuzick J; Forbes J; Edwards R; Baum M; Cawthorn S; Coates A; Hamed A; Howell A; Powles T;
    Lancet; 2002 Sep; 360(9336):817-24. PubMed ID: 12243915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast cancer risks and prevention: implications of the Breast Cancer Prevention Trial results.
    Crowell EB; Jubelirer SJ
    W V Med J; 2000; 96(6):598-601. PubMed ID: 11194088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study.
    Fisher B; Costantino JP; Wickerham DL; Cecchini RS; Cronin WM; Robidoux A; Bevers TB; Kavanah MT; Atkins JN; Margolese RG; Runowicz CD; James JM; Ford LG; Wolmark N
    J Natl Cancer Inst; 2005 Nov; 97(22):1652-62. PubMed ID: 16288118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. American Society of Clinical Oncology technology assessment on breast cancer risk reduction strategies: tamoxifen and raloxifene.
    Chlebowski RT; Collyar DE; Somerfield MR; Pfister DG
    J Clin Oncol; 1999 Jun; 17(6):1939-55. PubMed ID: 10561236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Weighing the risks and benefits of tamoxifen treatment for preventing breast cancer.
    Gail MH; Costantino JP; Bryant J; Croyle R; Freedman L; Helzlsouer K; Vogel V
    J Natl Cancer Inst; 1999 Nov; 91(21):1829-46. PubMed ID: 10547390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic review: comparative effectiveness of medications to reduce risk for primary breast cancer.
    Nelson HD; Fu R; Griffin JC; Nygren P; Smith ME; Humphrey L
    Ann Intern Med; 2009 Nov; 151(10):703-15, W-226-35. PubMed ID: 19920271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of medications to reduce risk for primary breast cancer: a systematic review for the U.S. Preventive Services Task Force.
    Nelson HD; Smith ME; Griffin JC; Fu R
    Ann Intern Med; 2013 Apr; 158(8):604-14. PubMed ID: 23588749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cost effectiveness of tamoxifen in the prevention of breast cancer.
    Noe LL; Becker RV; Gradishar WJ; Gore M; Trotter JP
    Am J Manag Care; 1999 Jun; 5(6 Suppl):S389-406. PubMed ID: 10538851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decision analysis of tamoxifen for the prevention of invasive breast cancer.
    Grann VR; Sundararajan V; Jacobson JS; Whang W; Heitjan DF; Antman KH; Neugut AI
    Cancer J; 2000; 6(3):169-78. PubMed ID: 10882333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular effects of tamoxifen in women with and without heart disease: breast cancer prevention trial. National Surgical Adjuvant Breast and Bowel Project Breast Cancer Prevention Trial Investigators.
    Reis SE; Costantino JP; Wickerham DL; Tan-Chiu E; Wang J; Kavanah M
    J Natl Cancer Inst; 2001 Jan; 93(1):16-21. PubMed ID: 11136837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endometrial cancer and venous thromboembolism in women under age 50 who take tamoxifen for prevention of breast cancer: a systematic review.
    Iqbal J; Ginsburg OM; Wijeratne TD; Howell A; Evans G; Sestak I; Narod SA
    Cancer Treat Rev; 2012 Jun; 38(4):318-28. PubMed ID: 21775065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Follow-up of the breast cancer prevention trial and the future of breast cancer prevention efforts.
    Vogel VG
    Clin Cancer Res; 2001 Dec; 7(12 Suppl):4413s-4418s; discussion 4411s-4412s. PubMed ID: 11916233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast cancer prevention trial.
    Elias EG; Brown SD; Buda BS; Honts SL
    Md Med J; 1994 Mar; 43(3):249-52. PubMed ID: 8201852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term results of tamoxifen prophylaxis for breast cancer--96-month follow-up of the randomized IBIS-I trial.
    Cuzick J; Forbes JF; Sestak I; Cawthorn S; Hamed H; Holli K; Howell A;
    J Natl Cancer Inst; 2007 Feb; 99(4):272-82. PubMed ID: 17312304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Is breast cancer prevention by tamoxifen possible?].
    Namer M; Serin D; Ferrero JM
    Bull Cancer; 1995 Jul; 82 Suppl 3():155s-167s. PubMed ID: 7492828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast carcinoma chemoprevention in the community setting. Estimating risks and benefits.
    Brewster AM; Christo DK; Lai H; Helzlsouer K
    Cancer; 2005 Mar; 103(6):1147-53. PubMed ID: 15674856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Base-line quality-of-life assessment in the National Surgical Adjuvant Breast and Bowel Project Breast Cancer Prevention Trial.
    Ganz PA; Day R; Ware JE; Redmond C; Fisher B
    J Natl Cancer Inst; 1995 Sep; 87(18):1372-82. PubMed ID: 7658498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.